Pliant Therapeutics, Inc.
PLRX
$1.38
-$0.09-6.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.56% | -30.35% | -29.88% | -28.38% | -28.60% |
| Total Depreciation and Amortization | 8.31% | 15.43% | 16.32% | 11.37% | 4.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.31% | 4.07% | 32.20% | 32.07% | 51.91% |
| Change in Net Operating Assets | -98.66% | 626.54% | 402.88% | -66.25% | 553.11% |
| Cash from Operations | -49.62% | -33.64% | -8.53% | -30.66% | -11.44% |
| Capital Expenditure | -16.36% | -317.81% | -260.62% | -78.01% | -75.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.94% | 214.35% | 199.23% | 140.51% | 133.57% |
| Cash from Investing | 40.44% | 210.49% | 195.84% | 139.51% | 132.75% |
| Total Debt Issued | -99.99% | -- | -- | -- | 99.09% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -43.27% | -98.83% | -98.79% | -99.27% | -99.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 97.85% | 92.91% | 76.03% |
| Cash from Financing | -92.01% | -91.58% | -91.53% | -95.23% | -95.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -268.72% | -74.37% | 79.31% | -9.91% | -81.06% |